| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 90999 |
Unlisted dialysis procedure, inpatient or outpatient |
13,251 |
1,113 |
$1.39M |
| A4657 |
Syringe, with or without needle, each |
313 |
286 |
$16K |
| Q4081 |
Injection, epoetin alfa, 100 units (for esrd on dialysis) |
8,739 |
599 |
$2K |
| 82728 |
|
136 |
134 |
$645.45 |
| J1270 |
Injection, doxercalciferol, 1 mcg |
1,675 |
146 |
$148.58 |
| J1756 |
Injection, iron sucrose, 1 mg |
1,460 |
371 |
$48.00 |
| 83540 |
|
140 |
137 |
$0.00 |
| 85041 |
|
414 |
404 |
$0.00 |
| 85048 |
|
398 |
390 |
$0.00 |
| 83970 |
|
273 |
235 |
$0.00 |
| J0887 |
Injection, epoetin beta, 1 microgram, (for esrd on dialysis) |
135 |
81 |
$0.00 |
| 0250 |
|
187 |
12 |
$0.00 |
| G0499 |
Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result |
15 |
15 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
87 |
87 |
$0.00 |
| 83550 |
|
128 |
125 |
$0.00 |